ARDX Earnings

ARDX reported its FY2025Q3 earnings on 2025-10-30, showcasing a revenue of 110.33M against an estimate of 100.54M, resulting in a 9.73% surprise. The EPS was 0, surpassing the expected -0.06 by 100%. The stock experienced a 20.96% price change on the earnings day and a 18.76% change over the next five days, reflecting market reactions to the results.

Following ARDX's FY2025Q3 earnings announcement on 2025-10-30, the stock price moved by 20.96% on the day of the release. Over the subsequent five days, it saw a 18.76% change. Historically, ARDX's stock price tends to shift by an average of -4.8% in the 10 days leading up to earnings and -0.01% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate ARDX's annual revenue to reach 104.40M, while the EPS is projected at -0.07. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ARDX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ARDX's stock price typically moves by -4.8% in the 10 days before its earnings and -0.01% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.07 and revenue of 104.40M.

The earnings call reflects strong financial performance with raised revenue guidance for IBSRELA and growth expectations for XPHOZAH. The company is investing in pipeline development and commercial expansion, indicating confidence in future growth. While management avoided giving guidance on sustained cash flow positivity, they highlighted strategic investments and infrastructure sufficiency. The Q&A session reveals a focus on innovation and market expansion, with management addressing key concerns. Given the market cap of $1.52 billion, the positive guidance and strategic initiatives are likely to result in a positive stock price movement of 2% to 8% over the next two weeks.